Financial reports
ARS
2010 FY
Annual report to shareholders
22 Apr 11
ARS
2004 FY
Annual report to shareholders
25 Apr 05
10-Q
2003 Q3
Quarterly report
28 Oct 03
10-Q
2003 Q2
Quarterly report
31 Jul 03
10-K/A
2002 FY
Annual report (amended)
30 Jun 03
ARS
2002 FY
Annual report to shareholders
23 Apr 03
10-Q
2003 Q1
Quarterly report
17 Apr 03
10-K
2002 FY
Annual report
14 Mar 03
10-Q
2002 Q3
Quarterly report
18 Oct 02
10-Q
2002 Q2
Quarterly report
14 Aug 02
Current reports
8-K
Financial statements and exhibits
28 Oct 03
8-K
Analysis of Antegren® Phase Iii Induction Clinical Trial In Crohn’s Disease Completed
29 Jul 03
8-K
Financial statements and exhibits
24 Jul 03
8-K
Biogen and Idec Pharmaceuticals Announce Merger to Create a New Biotechnology Industry Leader
23 Jun 03
8-K
Financial statements and exhibits
17 Apr 03
8-K
Financial statements and exhibits
4 Apr 03
8-K
Financial statements and exhibits
14 Mar 03
8-K
Other events
24 Feb 03
8-K
Other events
24 Feb 03
8-K
FDA APPROVES BIOGEN’S AMEVIVE® (alefacept) FOR TREATMENT OF PSORIASIS AMEVIVE is the first biologic treatment approved for psoriasis
31 Jan 03
Registration and prospectus
15-12G
Securities registration termination
13 Nov 03
POS AM
Prospectus update (post-effective amendment)
13 Nov 03
POS AM
Prospectus update (post-effective amendment)
13 Nov 03
S-8 POS
Registration of securities for employees (post-effective amendment)
13 Nov 03
S-8 POS
Registration of securities for employees (post-effective amendment)
13 Nov 03
S-8 POS
Registration of securities for employees (post-effective amendment)
13 Nov 03
S-8 POS
Registration of securities for employees (post-effective amendment)
13 Nov 03
S-8 POS
Registration of securities for employees (post-effective amendment)
13 Nov 03
S-8 POS
Registration of securities for employees (post-effective amendment)
13 Nov 03
S-8 POS
Registration of securities for employees (post-effective amendment)
13 Nov 03
Proxies
DEF 14A
Definitive proxy
17 Apr 03
DEF 14A
Definitive proxy
29 Apr 02
DEF 14A
Definitive proxy
30 Apr 01
DEFR14A
Revised proxy
11 May 00
DEF 14A
Definitive proxy
28 Apr 00
DEF 14A
Definitive proxy
10 May 99
PRE 14A
Preliminary proxy
23 Apr 99
DEF 14A
Definitive proxy
29 Apr 98
DEF 14A
Definitive proxy
30 Apr 97
DEF 14A
Definitive proxy
25 Apr 96
Other
No filings